Multisystem Inflammatory Syndrome in Children (MIS-C)

In News

Report shows that a significant number of young people with Multisystem Inflammatory Syndrome in Children (MIS-C) also develop neurological symptoms.

Multisystem Inflammatory Syndrome in Children (MIS-C)

• It is a newly identified and serious health condition associated with SARS-CoV-2 infection.
• It is a rare but severe hyperinflammatory condition in children and adolescents that typically occurs 2–6 weeks after acute SARS-CoV-2 infection.
• This was first described in Europe in April, 2020, and can affect multiple organ systems, including cardiac, gastrointestinal, haematological, dermatological, neurological, respiratory, and renal systems.

Neurological Complications associated with this

• A new report shows that a significant number of young people with the syndrome also develop neurological symptoms, including hallucinations, confusion, speech impairments and problems with balance and coordination.
• The new findings strengthen the theory that the syndrome is related to a surge of inflammation triggered by an immune response to the virus.

Causes of MIS-C

• Some researchers believe that MIS-C is a delayed response to the coronavirus which in turn causes massive inflammation in the body and as a result damages organs.
• Others believe it is a result of the children’s immune response making antibodies against the virus.
• However, due to the small percentage of children developing MIS-C symptoms, it is difficult for doctors and researchers to study the disorder.

Treatment & Diagnosis

• Currently, there is no single test to diagnose MIS-C. It is based on symptoms as well as several blood tests to look for signs of inflammation in the body.
• There is no singular treatment for MIS-C. Treatment involves managing the varying symptoms and correcting any abnormal lab findings.

Source: IE